Previous Article | Next Article ![]()
Molecular and Cellular Biology, June 2000, p. 4094-4105, Vol. 20, No. 11
Department of Microbiology and Immunology, Vanderbilt
University School of Medicine, Nashville, Tennessee
37232-2363,1 and Department of
Biochemistry and Molecular Genetics and Department of Pediatrics,
University of Colorado Health Sciences Center, Denver, Colorado
802622
Received 28 September 1999/Returned for modification 12 November
1999/Accepted 12 January 2000
The hnRNP C1 and C2 proteins are among the most abundant proteins
in the nucleus, and as ubiquitous components of RNP complexes, they
have been implicated in many aspects of mRNA biogenesis. In this
report, we have characterized a null mutation induced in embryonic stem
cells by insertion of the U3His gene trap retrovirus into the first
intron of the hnRNP C1/C2 gene. cDNAs encoding murine hnRNP C1 and C2
were characterized, and the predicted protein sequences were found to
be highly conserved among vertebrates. A human consensus sequence,
generated from over 400 expressed sequence tags, suggests two revisions
to the previously published human sequence. In addition, alternatively
spliced transcripts, expressed only by the murine gene, encode four
novel proteins: variants of C1 and C2 with either seven additional
amino acids or one fewer amino acid in a region between the
oligomerization and C-terminal acidic domains. The disrupted gene was
transmitted into the germ line and is tightly linked to a recessive,
embryonic lethal phenotype. Homozygous mutant embryos fail to develop
beyond the egg cylinder stage and are resorbed by 10.5 days of
gestation, a phenotype consistent with a fundamental role in cellular
metabolism. However, hnRNP C1 and C2 are not required for cell
viability. Embryonic stem cell lines established from homozygous mutant
blastocysts did not express detectable levels of either protein yet
were able to grow and differentiate in vitro, albeit more slowly than
wild-type cells. These results indicate that the C1 and C2 hnRNPs are
not required for any essential step in mRNA biogenesis; however, the proteins may influence the rate and/or fidelity of one or more steps.
Primary transcripts synthesized by
RNA polymerase II associate with a large number of nuclear RNA binding
proteins to form hnRNP complexes (13, 30, 55). These
RNA-protein complexes provide the substrates for processing and
transport of nuclear pre-mRNA. Purified hnRNP complexes contain over 20 proteins, designated according to size, from A1 (32 kDa) to U (120 kDa)
(41). The most abundant protein in the complex, hnRNP C1, is
expressed at approximately 90 million molecules per cell, levels
comparable to those for core histones (25). A related
protein, hnRNP C2, is thought to arise from differential splicing of
the same gene and is expressed at approximately one-third the level of
hnRNP C1 (6, 35). C1 and C2 proteins form stable
heterotetramers that bind cooperatively to RNA (32) and
contain both an RNA recognition motif (RRM) and a unique bZIP-like RNA
binding domain (31). Although the biochemical functions of
hnRNP C are unknown, the protein sequence is highly conserved among
vertebrates, suggesting an essential role in RNA metabolism.
Native transcripts isolated from gently disrupted nuclei sediment in
sucrose gradients as 30S to 250S dispersed material that appears by
electron microscopy as regular repeating arrays (5, 10) or
as clusters (50) of 20- to-25-nm particles. Following mild
nuclease digestion, this material is converted to morphologically homogeneous, 40S "monoparticles" (30). Purified 40S
monoparticles contain heterotetrameric complexes of hnRNP C1 and C2,
hnRNP A1 and B2, and hnRNP B1 and A2. These six proteins are the major constituents of the core hnRNP complex and together occupy
approximately 700 nucleotides (nt) of RNA (10). Three hnRNP
C tetramers together fold RNA into 19S triangular structures that
nucleate the assembly of 40S hnRNP complexes in vitro (22).
Assembly and disassembly of the core hnRNP complex have recently been
shown to be associated with RNA trafficking and nuclear export. hnRNP C
is the only member of the core complex that does not shuttle between
the nucleus and cytoplasm, as assessed by heterokaryon trafficking
experiments (43). The A and B proteins contain a nuclear
export signal (36), whereas the C proteins contain a nuclear
retention signal (39). The retention signal appears to
override export signals when both are incorporated into the same
protein, suggesting that removal of hnRNP C and/or remodeling of the
core complex may be a prerequisite for RNA transport from the nucleus.
Since hnRNP C is the most tightly bound component of the core
(5), such remodeling of riboprotein complexes is likely to
be a regulated, energy-dependent process. Furthermore, the protein is
preferentially phosphorylated during mitosis, suggesting that aspects
of hnRNP C function are regulated during the cell cycle (29,
42).
hnRNP C has been implicated in a variety of processes including
splicing, polyadenylation, and RNA turnover, but no clear consensus has
emerged concerning its biochemical function. Some reports place hnRNP C
within the spliceosome and suggest an active role for the protein in
splicing (8, 17, 40), whereas other studies indicate that
the hnRNP core proteins, including C, are displaced before the assembly
of the initial spliceosome complex (4). The functional
significance of interactions between hnRNP C and specific RNA sequences
is also unclear. Specific sequences, including those containing runs of
uridine and guanine residues, bind with relatively high affinity in a
context-specific manner. However, equilibrium-binding studies have
failed to uncover any preference for a limited number of sequences
involved in RNA processing (18, 49).
Overshadowing any effort to study activities of hnRNP C in vitro is the
fact that these highly abundant proteins may have pleiotropic effects
on RNA templates that are unrelated to their function. The nuclear
concentration of hnRNP C (10 µM) is sufficient to saturate all RNA in
the nucleus. The bound tetramers occupy approximately 230 nt of RNA and
induce changes in RNA secondary and tertiary structure (22,
44). Consequently, biochemical approaches alone are unlikely to
resolve physiologic functions of hnRNP C.
Efforts to understand the function of hnRNP proteins have been hampered
by the lack of practical systems for genetic analysis. In principle,
the function of hnRNP C, which has been found only in vertebrates,
could be addressed by gene targeting experiments followed by the
derivation of null cell lines. However, this approach assumes that the
protein will not be required for cell viability, an uncertain prospect
in light of its abundance, sequence conservation, and presumed role in
mRNA biogenesis.
Our laboratory has developed strategies for large-scale insertional
mutagenesis in mice. The targeting vectors contain a selectable marker
in the U3 region of the long terminal repeat (LTR) of a replication-defective Moloney murine leukemia virus (20).
Infection of embryonic stem (ES) cells followed by selection for U3
gene expression generates clones in which the virus has integrated into
expressed cellular genes. Genes disrupted by the provirus can be
introduced into the germ line to study gene functions in vivo. This
report characterizes the 4A4 mutation (53) which results
from insertion of the U3His gene trap vector into the first intron of
the hnRNP C1/C2 gene. Embryos homozygous for the mutation fail to
develop beyond the egg cylinder stage and are resorbed between 6.5 to
10.5 days of gestation. However, cell lines derived from
preimplantation mutant embryos are viable and are able to differentiate
in vitro. This is the first report of a null mutation in a member of
the hnRNP gene family and suggests that genetic approaches will be
useful to understand the functions of even highly abundant proteins
involved in mRNA biogenesis.
Nucleic acid isolation and genotyping of embryos.
Mouse DNA
was isolated from tail biopsies, cultured cells, or mouse embryos as
described previously (26). Total cellular RNA was isolated
from tissue culture cells or from mouse tissues by guanidinium
isothiocyanate lysis followed by phenol-chloroform extraction
(9). For Northern blot analysis, 20 µg of RNA was denatured in 1.1 M glyoxal, 50% dimethyl sulfoxide, and 10 mM sodium
phosphate (pH 7.0) at 50°C for 1 h. Samples were separated on a
1.2% agarose gel and blotted onto Hybond N+ membrane (Amersham). Hybridization to [32P]dCTP-labeled probes (15)
for both Southern and Northern analysis was carried out in 10% dextran
sulfate-50% formamide-5× SSPE (1× SSPE is 0.18 M NaCl, 10 mM
NaH2PO4, and 1 mM EDTA [pH 7.7])-1× Denhardt's solution-20 µg of salmon sperm DNA per ml.
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
hnRNP C Is Required for Postimplantation Mouse Development
but Is Dispensable for Cell Viability
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Isolation of genomic and cDNA clones encoding the hnRNP C1/C2
proteins.
DNA sequences (65 nt) adjacent to the 4A4 provirus were
isolated by inverse PCR (iPCR) (53). This fragment was used
to isolate a genomic clone containing an 11-kb insert. A
SacII-HindIII fragment spanning the site of
virus integration was then used to screen a random-primed ES cell cDNA
library. We identified 57 positive plaques from a total of
approximately 106. Two cDNA inserts were characterized and
found to terminate approximately 100 bp prior to the published stop
codon of the human gene. Therefore, a 970-bp
AccI-PvuII cDNA fragment was isolated from one of
the cDNA clones and used to screen an 8.5-day mouse embryonic cDNA
gt10 library. We identified 138 positive plaques out of a total of
approximately 2.5 × 105, suggesting that hnRNP C
transcripts constitute approximately 0.05% of the total mRNA of the
8.5-day embryo. Five positive plaques were purified, and all were found
to contain similar 1.2-kb inserts. An insert from a single clone was
isolated and found to terminate with a poly(A) tail. Together, the
three overlapping cDNA clones constituted the entire coding sequence of
the mouse hnRNP C1 and C2 proteins.
Isolation of ES cells. ES cells lines were isolated essentially according to Evans and Kaufman (14), as detailed by Robertson (46). Briefly, the 4A4 mutation, which had been maintained on a C57BL/6 background, was outbred onto an 129/Sv background for three generations. Heterozygous mice were mated. Visual inspection for a vaginal plug was used to time pregnancies as day 0.5. Female mice were sacrificed on day 3.5, and the uterine horns were dissected and flushed with ES cell medium (high-glucose Dulbecco modified Eagle medium [Gibco] supplemented with 15% preselected fetal bovine serum [heat inactivated at 55°C for 30 min; HyClone], 0.1 mM 2-mercaptoethanol, and 100 mM nonessential amino acids [Gibco]). All blastocysts appeared normal, suggesting that the disruption of the hnRNP C gene has no effect on preimplantation development. Individual blastocysts were isolated and transferred to single wells of a 24-well plate containing an established feeder cell layer of gamma-irradiated primary mouse embryo fibroblasts (MEFs) with culture-conditioned ES cell medium. Blastocysts were left undisturbed for 4 days of tissue culture. During this time, the inner cell mass (ICM) begins to outgrow from the trophoblastic cells. The growth of the ICM was closely monitored between 4 and 6 days of culture and, when it reached sufficient size (46), was dissected away from the accompanying trophoblastic cells by using a blunted, drawn-out Pasteur pipette. The ICM was transferred to a culture dish containing phosphate-buffered saline (PBS) and then transferred to a 96-well plate containing 0.25% (wt/vol) trypsin and 0.04% (wt/vol) EDTA in PBS. The ICM was triturated using a 100-µl pipette tip. The resulting small clumps of cells were then seeded back into a single well of a 24-well plate containing a previously established MEF feeder layer. Subsequently, each well was trypsinized every 3 days and replated onto a fresh feeder layer. Wells in which ES cells arose were expanded to subconfluence on a 10-cm-diameter tissue culture plate. Aliquots of cells were frozen (50% Dulbecco modified Eagle medium [DMEM]-38% fetal bovine serum-12% dimethyl sulfoxide), and the remainder were expanded for further characterization.
Characterization of alternative 3' splice sites. Primers (5'-CTTCTATCGCCTTCTTGACG and 5'-ACACAGATAAGTTGCTGGCC) complementary to the murine hnRNP C1/C2 cDNA sequence were used to amplify intervening intron sequences by PCR (see above) involving 35 cycles of denaturation (95°C for 45 s), primer annealing (55°C for 45 s), and primer extension (72°C for 1.5 min). Two products of 200 and 320 nt were generated. The 200-nt fragment is of the size expected if there were no intervening intron sequences and was probably amplified from one or more hnRNP C pseudogenes. The 320-nt fragment, containing an intron and alternative 3' splice sites, was cloned into a TA cloning vector (Invitrogen) and sequenced.
Cell culture and protein purification. Cells were maintained on 0.1% gelatinized tissue culture plates in ES cell medium (see above) supplemented with leukemia inhibitory factor (1,000 U/ml; ESGRO; Gibco). Cultures were trypsinized every 2 days and replated at a 1:3 ratio with either a feeder layer of gamma-irradiated MEFs for maintenance of the cell line or for at least three generations without feeder layers for isolation of DNA, RNA, and cell extracts. For whole cell extracts, cells were harvested, washed twice with cold PBS, pelleted, and resuspended in EBC buffer (50 mM Tris [pH 7.5], 100 mM NaCl, 0.5% NP-40 [22]; 0.5 ml/10-cm-diameter plate) containing the protease inhibitors antipain, leupeptin, pepstatin A, and chymostatin at 50 µg/ml each and 4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF; Calbiochem) at 0.2% (wt/vol). Following 30 min of constant agitation at 4°C, samples were clarified by centrifugation.
Nuclear extracts (NE) were prepared as previously described (41), with slight modifications. Adherent cells were washed twice with PBS and lysed with buffer A (10 mM Tris [pH 7.4], 100 mM NaCl, 2.5 mM MgCl2; 1 ml/10-cm-diameter plate) containing 0.5% Triton X-100, aprotinin (4 µg/ml), leupeptin (1 µg/ml), soybean trypsin inhibitor (5 µg/ml), and pepstatin A (4 µg/ml). Nuclei were pelleted, resuspended in 1/10 volume of buffer A without Triton X-100 containing the same protease inhibitors as above, and sonicated on ice with three 15-s bursts, using a microtip sonicator (model XL2015; Heat Systems) at a setting of 3.5. The sonicate was centrifuged at 14,000 rpm for 15 min, and the supernatant was flash frozen in liquid N2. A single-step chromatography purification protocol was developed based on a previous procedure (3). A 4.5-mg aliquot of either wild-type ES cell or mutant cell NE was loaded onto individual 1-ml HiTrap Q (Amersham Pharmacia Biotech) anion-exchange columns equilibrated with buffer A. The columns were washed with 5 column volumes (CV) of buffer A and then developed with a step gradient of increasing NaCl concentration (0.25, 0.5, and 1.0 M with 5 CV per step). A constant flow rate of 0.5 ml/min was maintained throughout, and protein elution was monitored at 214 nm. One-milliliter fractions were collected, aliquots were taken for protein concentration determination, and the remaining samples were precipitated with 3 volumes of 100% ethanol. Pellets were resuspended in Laemmli loading buffer and analyzed by Western blotting.Western blotting analysis. Protein concentrations were determined by the Bradford assay. Samples were adjusted to 1× Laemmli loading buffer (47), boiled for 10 min, and fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on an 8.75% gel. Proteins were transferred onto PolyScreen polyvinylidene difluoride membrane (NEN Life Sciences) in Tris-glycine buffer (47). Polyclonal serum from chickens (Ab-1041; Aves Laboratories) immunized against a C-terminal peptide (Val 140-Gly 290) of human hnRNP C1 was diluted 1:2,000 in BLOTTO A (5% milk and 0.05% Tween 20 in Tris-buffered saline [TBS; 10 mM Tris-HCl, 150 mM NaCl]) and bound to proteins overnight at 4°C. Membranes were washed three times for 5 min each in TBS-0.05% Tween 20, incubated with a 1:5,000 dilution of peroxidase-conjugated anti-chicken Fc fragment (Jackson ImmunoResearch) in BLOTTO A, and detected by SuperSignal ECL (enhanced chemiluminescence) (Pierce).
Nucleotide sequence accession number. The sequences shown in Fig. 1C, 2, and 3 have been assigned GenBank accession no. AF095256, AF095257, and AF095258, respectively.
| |
RESULTS |
|---|
|
|
|---|
The 4A4 provirus integrates into the hnRNP C gene.
The 4A4
cell line was generated by infecting D3-ES cells with the U3His gene
trap retrovirus and selecting for L-histidinol-resistant clones. 4A4 cells contain a single intact provirus as assessed by
Southern blot hybridization, and expression of the proviral His gene occurs via transcripts that initiate in the
flanking cellular DNA (53). To identify the gene disrupted
in the 4A4 cell line, a 65-nt sequence, extending to an MseI
site immediately upstream of the provirus, was isolated by iPCR
(54). When used as a probe in Southern blot analyses, the
iPCR fragment hybridized to single-copy cellular DNA and could
therefore distinguish the wild-type genomic sequence from the locus
occupied by the provirus (Fig. 1B). For
example, a unique fragment corresponding to the wild-type allele is
detected in StuI digested DNA from the parental D3 cell line
(Fig. 1B, lane 5). An additional fragment is detected in DNA from the
4A4 clone (Fig. 1B, lane 6). The more slowly migrating fragment also
hybridized to a virus-specific probe (Fig. 1B, lanes 7 and 8) and
corresponded to the expected size of the intact 6.8-kb U3His provirus.
These data confirm that the 4A4 mutant cell line contains a single
provirus and suggest that no rearrangements occurred within the virus
or flanking cellular DNA as a result of virus integration.
|
DASH I D3-ES cell
library. A single clone was isolated, mapped, and sequenced on either
side of the integration site (Fig. 1C). The genomic clone provided
several fragments for use as probes in Northern blot experiments (data
not shown). A 950-nt SacII-HindIII fragment
(Fig. 1A), spanning the provirus integration site, hybridized to a
prominent 1.4-kb transcript and was used to screen two separate ES cell
cDNA libraries (see Materials and Methods). Three independent clones
were isolated and sequenced.
The 5' ends of the cDNA sequences were identical to a region in the
flanking genomic DNA. The match extended for 94 nt and ended at a
consensus 5' splice site located 286 nt upstream of the virus
integration site (Fig. 1C, shaded box). The cDNA sequences were also
compared against the GenBank database by using the Gapped BLAST program
(1). All three cDNAs were orthologous to the human hnRNP
C1/C2 gene (7). Moreover, patterns of alternative splicing
that generate the human C1 and C2 proteins were also observed, with the
C1 and C2 transcripts represented by one and two cDNAs, respectively.
Together, these results indicate that the 4A4 provirus inserted into an
intron of the murine hnRNP C1/C2 gene. The original 65-nt iPCR sequence
is entirely contained within the intron, accounting for the failure of
this probe to hybridize to cellular transcripts.
Murine hnRNP C1 and C2 cDNA sequences.
The three cDNAs
together contained the entire coding sequence for both the C1 and C2
proteins and terminated at a consensus polyadenylation site. Figure
2 shows the composite sequence of the
cDNA encoding mouse hnRNP C2. The 39-nt region missing from hnRNP C1 is
enclosed in a shaded box. Differences between the murine and previously
reported human hnRNP C2 cDNA sequences include 10 single-codon changes
and an additional 21 nucleotides that add seven amino acids to the
murine sequence (amino acids 227 to 233). Furthermore, the presence of
two additional nucleotides adds three amino acids to the C terminus of
the murine sequence. Overall, the colinear portions of human and murine
proteins are 97% identical. Except for a single amino acid in C2, the
mouse and human proteins are identical over the N-terminal portion
containing the RRM, highlighting the potential functional importance of
this domain.
|
Species-specific splicing of hnRNP C transcripts.
The most
striking difference between the murine and human cDNA sequences was the
21-nt insert present in all three murine cDNAs. To determine
whether the 21-nt sequence is derived from an alternatively spliced
exon, a region of the murine gene was amplified by PCR and sequenced.
In designing PCR primers, we postulated that cDNA sequences on either
side of the 21-nt insert could be used to amplify an intervening
intron. This assumption proved correct. As shown in Fig.
3, the extra murine sequence results from
the use of an alternative 3' splice site, designated C
, located 21 nt upstream from the human splice site (C
). However, a sequence
resembling a 3' splice site was also observed at the murine C
site.
Therefore, it was of interest to determine if any murine transcripts
utilized the C
site and if any human transcripts utilized the C
upstream site. For this, we examined all 91 ESTs (43 human and 48 mouse) from dbESTs containing this region of hnRNP C. The murine ESTs
fell into three groups, indicative of transcripts that splice from a
single 5' splice site to one of three alternative 3' splice sites (Fig.
3). Twenty-seven (56%) were derived from transcripts splicing to the
upstream site (C
), as observed in our original murine cDNAs; 13 (27%) involved transcripts using the same 3' splice site (C
) as the
published human sequence; 8 (17%) spliced to an AG (C
) three
nucleotides downstream from the human site (Fig. 3). In contrast, all
of the human ESTs utilized the C
site. The murine and human ESTs
were independently cloned from a variety of tissues; therefore, the
mouse gene appears to be alternatively spliced in a species-specific
manner and could encode six proteins: variants of C1 and C2 utilizing
each of the three splice acceptor sites (C1
, C1
, C1
, C2
,
C2
, and C2
).
|
hnRNP C is essential for postimplantation mouse development. To characterize phenotypes associated with viral disruption of the C1/C2 gene, the 4A4 ES cell line was injected into C57BL/6 blastocysts (53). The resulting chimeras transmitted the 4A4 provirus to their offspring. Mice heterozygous for the provirus were normal in all respects. However, mice homozygous for the disrupted hnRNP C gene were not detected in over 220 offspring produced from heterozygote crosses (data not shown). This analysis included progeny obtained after nine backcrosses into a C57BL/6 background; therefore, transmission of the 4A4 provirus appears to be tightly linked to a recessive embryonic lethal mutation.
To more precisely determine the time and cause of embryonic death, intercrossed females were sacrificed at various days postcoitum (dpc). Individual embryos were dissected from the deciduum and genotyped by Southern analysis (9.5 and 10.5 dpc) or by PCR (6.5 to 8.5 dpc). As shown in Table 1, the proportion of wild-type to heterozygous mutant embryos was approximately 1:2 at each stage between E6.5 and E10.5. The yield of embryos homozygous for the mutation was less than expected, presumably because they were being resorbed and could not be accurately genotyped. Except for one necrotic embryo, none of the embryos at E10.5 was homozygous for the mutation, and approximately one-fourth of all embryos (20 of 71; 27%) had undergone resorption. Greater numbers of homozygous mutant embryos were observed at earlier stages, and the proportion of resorbed embryos was lower. However, even at E6.5, a significant number of embryos had already been resorbed.
|
|
Derivation of ES cells from mutant blastocysts.
One
explanation for the phenotype of the mutant embryos is that disruption
of hnRNP C leads to a generalized cell lethal defect but that mutant
embryos persist until implantation due to maternally derived stores of
mRNA or protein. Although the majority of maternal RNA is rapidly
degraded following the onset of de novo transcription at the first cell
division (2, 16, 23), it has been suggested that abundant
transcripts, such as hnRNP C, could persist for several days.
Therefore, to determine whether hnRNP C is required for cell viability,
we attempted to derive a homozygous mutant ES cell line from
preimplantation blastocysts (14, 21). Previous observations
from our laboratory and others (24) suggest that derivation
of ES cell lines is more consistent when mice are bred onto the 129/Sv
background. Therefore, mice carrying the 4A4 mutation (C57BL/6
background) were first bred with 129/Sv mice for three generations.
F3 heterozygous mice were mated, and blastocysts were
collected at 3.5 dpc and cultured as described in Materials and
Methods. Out of 21 blastocysts isolated from four females, eight
individual cell lines were established. As shown in Fig. 5A, two cell lines were homozygous for
the hnRNP C mutation. Both mutant cell lines appeared morphologically
similar to other ES cell lines (see Fig. 7A and F) and grew with
doubling times of approximately 24 h (data not shown).
|
hnRNP C is not required for cell viability. U3 gene trap vectors were designed to disrupt cellular gene expression by ablating transcription downstream from the two poly(A) sites (one in each LTR) carried by the provirus. Previous studies found high levels of a 2.2-kb His transcripts in 4A4 cells (53), approximately the size expected for hnRNP C-His fusion transcripts that terminate in the 5' LTR. To test whether the 4A4 provirus indeed disrupts expression of the hnRNP C gene, homozygous mutant cell lines were analyzed by Northern blot analysis (Fig. 5B) using an hnRNP C cDNA probe containing sequences downstream of the virus integration site. Transcripts of 1.4, 1.9, and 3.0 kb were detected in the wild-type and heterozygous cell lines but not in the two mutant cell lines, indicating that expression is disrupted in the mutant cells. The closest known relative of hnRNP C is Raly, a gene discovered by its linkage to the lethal yellow (Ay) mutation (37). Given the similarity of these two proteins, we measured the levels of Raly transcripts to see if there was compensatory activation of this message in the mutant cells. As shown in Fig. 5B, no increase in Raly transcripts was observed in the mutant cell lines.
hnRNP C protein expression was assessed by Western blot analysis of whole cell extracts, NE, and NE partially purified by anion-exchange chromatography. hnRNP C could be detected in wild-type cell extracts containing as little as 5 µg of total protein. Heterozygous ES cells appear to contain similar levels of protein, consistent with Northern blot data (see above). No hnRNP C was detected in homozygous cells even when larger amounts (up to 300 µg) of cell protein were analyzed. However, a number of cross-reacting background bands migrating in the 40- to 45-kDa range were observed in the overloaded samples. Since hnRNP C is specifically retained within the nucleus, preparations of NE are expected to be enriched for the protein. As seen in Fig. 6B, hnRNP C was clearly detected in samples of wild-type NE containing as little as 250 ng of total protein, and a faint signal was seen with 125 ng upon overexposure (data not shown). Again, no protein was detected in NE from mutant cells even when larger samples were analyzed. Some nonspecific background was observed when higher levels of mutant NE were examined. This background included two proteins, approximately 40 and 45 kDa in size, that migrated slightly faster and slower than hnRNP C1/C2, respectively.
|
Cells lacking hnRNP C differentiate in vitro.
The fact that
mutant embryos arrest in development prior to gastrulation raises the
possibility that hnRNP C may directly influence the differentiation
potential of the developing embryo. ES cells have the ability to
differentiate in vitro into a wide range of cellular phenotypes.
Therefore, mutant ES cell lines lacking hnRNP C provide a model with
which to test whether this protein is required for cellular
differentiation. Figure 7 shows the
phenotypes of both wild-type ES cells and homozygous
mutant cells at various times of in vitro differentiation. After 4 days in suspension culture, both wild-type and mutant cells aggregate to
form simple embryoid bodies (EBs) (Fig. 7B and G). Whereas EBs derived
from wild-type ES cells had already formed a distinct outer layer of
endoderm cells (Fig. 7B), formation of a similar endoderm layer in
mutant EBs was delayed approximately 2 days (Fig. 7H). After replating,
wild-type EBs quickly attached to the culture dish and within 2 days
developed large trophoblast-like outgrowths (Fig. 7C). By 10 days in
culture, wild-type cells differentiated into several morphologically
distinct cell types, including blood islands and beating cardiac tissue
(Fig. 7D and E). EBs derived from the mutant cells were slow to form
trophoblastic outgrowths (Fig. 7I), and only about 10% survived longer
than 1 week. The mutant EBs that did survive were able to differentiate
in a manner morphologically similar to that of wild-type cells (Fig.
7J). However, the differentiation process took nearly 3 to 4 weeks for
the mutant cells, compared to 1 to 2 weeks for wild-type cells.
|
| |
DISCUSSION |
|---|
|
|
|---|
Mutagenesis of murine ES cells by gene entrapment provides an effective means to analyze gene functions in mice. The mutagens permit direct selection of clones in which cellular genes have been disrupted and simplify the characterization of genes associated with recessive mutations. The present study characterized a null mutation in the murine hnRNP C gene induced by the U3His gene trap vector. The mutation was introduced into the germ line and results in early embryonic death. However, hnRNP C is not required for cell viability, as ES cells derived from homozygous mutant blastocysts are viable and undergo morphological differentiation in vitro.
cDNAs encoding murine C1 and C2 hnRNPs were characterized as part of our analysis of the 4A4 mutation, providing the second mammalian and third vertebrate hnRNP C sequenced to date. Overall, murine hnRNP C shares 97 and 78% sequence identity with the human and Xenopus proteins, respectively. C1 and C2 hnRNPs are encoded separately by both murine and human cDNAs. Neither protein is expressed in cells homozygous for the 4A4 mutation, confirming that both are expressed by a single gene. Phylogenetic conservation of the C1 and C2 proteins suggests that both have distinct functions in mRNA biogenesis.
Additional alternative splicing of murine hnRNP C1 and C2 transcripts
generates three proteins of each type, designated C1
, C1
, and
C1
(for hnRNP C1) and C2
, C2
, and C2
(for hnRNP C2). The
murine C1
and C2
proteins are colinear with human C1 and C2,
respectively. The
and
forms, expressed only in the mouse, contain either seven additional amino acids (
) or one fewer amino acid (
) immediately following Asp 226. Significant levels of all
three types appear to be expressed, with the least abundant
form
comprising 17% of all ESTs. In addition, each type was present in cDNA
libraries cloned from a variety of tissues. However, the
and
forms are not conserved among mammals, casting doubt as to their
functional significance. The variable sequence may simply serve as a
spacer between a region involved in oligomerization (31) and
the acidic C-terminal domain.
During the course of these studies, we found two differences between
the previously published HeLa cDNA sequence (52) and all
available human ESTs. Human ESTs encode isoleucine at position 218 instead of methionine and contain two additional nucleotides that
extend the reading frame, resulting in the addition of three amino
acids. In both cases, the murine gene sequence (Fig. 2) is the same as
those of the human ESTs. The revision to Ile at position 218 is
potentially significant, as it occurs in a region important for the
formation of hnRNP C tetramers (31) and extends a potential
amphipathic domain by seven amino acids (i.e., one
-helical turn).
Similar domains in other proteins are associated with coiled-coil
protein interactions (28).
This is the first null mutation described for any member of the large
family of abundant hnRNP proteins. The fact that homozygous mutant
embryos fail to develop beyond E6.5 (egg cylinder stage) demonstrates
that hnRNP C provides nonredundant functions essential to the organism.
As early embryonic death appears to be a common consequence of
mutations disrupting basic cellular processes (11), the
phenotype is consistent with the important role hnRNP C is thought to
play in RNA metabolism. Mutations in other genes implicated in RNA
processing have produced similar phenotypes. For example, a gene
trap-induced mutation in Fugl
the murine homologue of yeast RNA1, a Ran GTPase-activating protein involved in nuclear
transport
leads to a similar embryonic lethality at E6.5
(12). Deletion of Raly, an hnRNP C-related gene,
is associated with the recessive, preimplantation lethal component of
the Ay mutation (37) which also
arrests development prior to gastrulation. While more severe than the
hnRNP C null phenotype, Ay is genetically
complex and involves more than the loss of Raly function.
Although the first 6.5 days of embryonic development are characterized by a progressive increase in cell number, very little increase is seen in the overall mass or volume of the embryo (34). However the requirement for macromolecular synthesis increases dramatically around E6.5. Prior to gastrulation, cell doubling times decrease from about 11.5 h at E5.5 to less than 5 h at E6.5 (48). An even greater increase is seen in embryonic volume. Between E5.5 and E6.5, the volume of the embryo progresses from 3.4 × 105 to 9.0 × 105 µm3, a 2.6-fold increase. By E7.5, the embryonic volume expands to approximately 1.3 × 107 µm3, a 14.4-fold increase. There is accumulating evidence that this increase in growth rate is required for mesoderm induction (45) and that mutations that depress cell proliferation cause developmental arrest at E6.5 similar to what occurs with the hnRNP C mutation (19, 27, 38, 51). Therefore, hnRNP C (and possibly Fugl and Raly) mutant embryos may arrest at the egg cylinder stage, not because of a specific developmental defect but rather due to their inability to keep pace with the large metabolic demands required at the onset of gastrulation.
An important feature of using mice as a genetic system is the potential for generating isogenic cell lines deficient in specific genes for analysis of the biochemical functions of the encoded proteins. Cell lines can be isolated, as in the present study, even when the mutation results in early embryonic death. Cell lines were established from 8 of 21 blastocysts, of which 2 were homozygous for the 4A4 mutation. Cells from homozygous mutant embryos expanded more slowly than cells from heterozygous and wild-type embryos, requiring nearly twice as long to reach each successive passaging interval. Once established, the mutant cells grew somewhat slower than normal cells.
With cell lines it was possible to assess the consequences of provirus insertion on cellular gene expression. Such experiments are difficult, it not impossible, to perform in embryos prior to E7.0. Since the 4A4 provirus is inserted into an intron, we were concerned that some transcripts might splice around the provirus, allowing residual gene expression. However, we were unable to detect hnRNP C protein or message in cells homozygous for the 4A4 provirus. Within the limits of detection, mutant cells express at least 5,000-fold less hnRNP C than wild-type cells, reflecting an essentially null mutation.
hnRNPs C1/C2, A1/B2, and B1/A2 are among the most abundant proteins in the nucleus, with levels comparable to those of the core histones. These levels are sufficient to package nuclear RNA into repeating arrays of 20- to 25-nm RNP particles (30). Riboprotein complexes, and not RNA, constitute the substrates for all transport and processing steps involved in mRNA biogenesis. Consequently, we did not expect that cells lacking hnRNP C would be viable. We considered the possibility that hnRNP C might function specifically during cell differentiation, with relatively little effect on undifferentiated ES cells. However, mutant cells retain, at least on a qualitative level, the capacity for in vitro differentiation. Moreover, ES cells are not unique in the ability to tolerate mutations in core RNPs. A murine erythroleukemia cell line that expresses only nominal levels of hnRNP A1/B2 has been described (56).
In principle, other RNA binding proteins may substitute for the loss of hnRNP C. For example, ES cells express high levels of Raly transcripts (Fig. 5B), which is 41% identical to hnRNP C at the amino acid level. However, Raly has not been found among the RNA binding proteins present in hnRNP complexes. Whether another protein can substitute for hnRNP C or not, cells appear to tolerate some plasticity in the structure of hnRNP complexes. Preliminary analysis of gene expression and RNA processing in hnRNP C-deficient cells has thus far failed to reveal differences between wild-type and mutant cells. For example, we observed no difference in the expression of a luciferase reporter gene either over a range of DNA concentrations or at various times after gene transfer (S. Banik-Maiti and H. E. Ruley, unpublished data). Similarly, no striking differences were observed (Banik-Maiti and Ruley, unpublished data) in the levels of expression or splicing patterns of a human growth hormone gene (33). In short, the loss of hnRNP C has far less effect than might be expected considering the abundance of the protein and previous notions about its function. While the available data suggest that the C1 and C2 hnRNPs are not required for any essential step in mRNA biogenesis, the proteins presumably influence the rate and/or fidelity of one or more steps, given the phenotypes observed in mutant cells and mice. While additional experiments are required for a more detailed understanding of hnRNP C functions, the hnRNP C-deficient cell lines described in this report should prove useful in such endeavors.
| |
ACKNOWLEDGMENTS |
|---|
We thank Wallace LeStourgeon for critical review of the paper, for help with hnRNP C protein purification, and for the anti-hnRNP C antibody. We also thank Edward J. Michaud for the Raly (EcDNA 1) cDNA clone; Brigid Hogan and Robert Rosenberg for providing the 8.5-day mouse embryo and ES cell cDNA libraries, respectively; and Richard Bucco, Erica White, Jin Chen, and James McAfee for helpful discussions.
This work was supported by Public Health Service grants (R01HG00684 and R01RR13266 to H.E.R.) and by a grant from the Kleberg Foundation. Additional support was provided by a Cancer Center (Core) grant. D.J.W. was supported by Medical Scientist Training Grant 5T32-GM07347.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology and Immunology, Room AA5206 MCN, Vanderbilt University School of Medicine, 1161 21st Ave. South, Nashville, TN 37232-2363. Phone: (615) 343-1379 or (615) 343-2087. Fax: (615) 343-7392. E-mail: ruleye{at}ctrvax.vanderbilt.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Altschul, S. F.,
T. L. Madden,
A. A. Schaffer,
J. Zhang,
Z. Zhang,
W. Miller, and D. J. Lipman.
1997.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402 |
| 2. | Bachvarova, R., and V. De Leon. 1980. Polyadenylated RNA of mouse ova and loss of maternal RNA in early development. Dev. Biol. 74:1-8[CrossRef][Medline]. |
| 3. | Barnett, S. F., W. M. LeStourgeon, and D. L. Friedman. 1988. Rapid purification of native C protein from nuclear ribonucleoprotein particles. J. Biochem. Biophys. Methods 16:87-97[CrossRef][Medline]. |
| 4. |
Bennett, M.,
S. Michaud,
J. Kingston, and R. Reed.
1992.
Protein components specifically associated with prespliceosome and spliceosome complexes.
Genes Dev.
6:1986-2000 |
| 5. | Beyer, A. L., M. E. Christensen, B. W. Walker, and W. M. LeStourgeon. 1977. Identification and characterization of the packaging proteins of core 40S hnRNP particles. Cell 11:127-138[CrossRef][Medline]. |
| 6. |
Burd, C. G., and G. Dreyfuss.
1994.
Conserved structures and diversity of functions of RNA-binding proteins.
Science
265:615-621 |
| 7. |
Burd, C. G.,
M. S. Swanson,
M. Gorlach, and G. Dreyfuss.
1989.
Primary structures of the heterogeneous nuclear ribonucleoprotein A2, B1, and C2 proteins: a diversity of RNA binding proteins is generated by small peptide inserts.
Proc. Natl. Acad. Sci. USA
86:9788-9792 |
| 8. |
Choi, Y. D.,
P. J. Grabowski,
P. A. Sharp, and G. Dreyfuss.
1986.
Heterogeneous nuclear ribonucleoproteins: role in RNA splicing.
Science
231:1534-1539 |
| 9. | Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159[Medline]. |
| 10. |
Conway, G.,
J. Wooley,
T. Bibring, and W. M. LeStourgeon.
1988.
Ribonucleoproteins package 700 nucleotides of pre-mRNA into a repeating array of regular particles.
Mol. Cell. Biol.
8:2884-2895 |
| 11. | Copp, A. J. 1995. Death before birth: clues from gene knockouts and mutations. Trends Genet. 11:87-93[CrossRef][Medline]. |
| 12. |
DeGregori, J.,
A. Russ,
H. von Melchner,
H. Rayburn,
P. Priyaranjan,
N. A. Jenkins,
N. G. Copeland, and H. E. Ruley.
1994.
A murine homolog of the yeast RNA1 gene is required for postimplantation development.
Genes Dev.
8:265-276 |
| 13. | Dreyfuss, G., M. J. Matunis, S. Pinol-Roma, and C. G. Burd. 1993. hnRNP proteins and the biogenesis of mRNA. Annu. Rev. Biochem. 62:289-321[CrossRef][Medline]. |
| 14. | Evans, M. J., and M. H. Kaufman. 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154-156[CrossRef][Medline]. |
| 15. | Feinberg, A. P., and B. Vogelstein. 1984. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137:266-267[CrossRef][Medline]. |
| 16. | Flach, G., M. H. Johnson, P. R. Braude, R. A. Taylor, and V. N. Bolton. 1982. The transition from maternal to embryonic control in the 2-cell mouse embryo. EMBO J. 1:681-686[Medline]. |
| 17. |
Forne, T.,
F. Rossi,
E. Labourier,
E. Antoine,
G. Cathala,
C. Brunel, and J. Tazi.
1995.
Disruption of base-paired U4.U6 small nuclear RNAs induced by mammalian heterogeneous nuclear ribonucleoprotein C protein.
J. Biol. Chem.
270:16476-16481 |
| 18. |
Gorlach, M.,
C. G. Burd, and G. Dreyfuss.
1994.
The determinants of RNA-binding specificity of the heterogeneous nuclear ribonucleoprotein C proteins.
J. Biol. Chem.
269:23074-23078 |
| 19. | Hakem, R., J. L. de la Pompa, C. Sirard, R. Mo, M. Woo, A. Hakem, A. Wakeham, J. Potter, A. Reitmair, F. Billia, E. Firpo, C. C. Hui, J. Roberts, J. Rossant, and T. W. Mak. 1996. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85:1009-1023[CrossRef][Medline]. |
| 20. | Hicks, G. G., E. G. Shi, J. Chen, M. Roshon, D. Williamson, C. Scherer, and H. E. Ruley. 1995. Retrovirus gene traps. Methods Enzymol. 254:263-275[Medline]. |
| 21. | Hogan, B., R. Beddington, F. Costantini, and E. Lacy. 1994. Manipulating the mouse embryo: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 22. |
Huang, M.,
J. E. Rech,
S. J. Northington,
P. F. Flicker,
A. Mayeda,
A. R. Krainer, and W. M. LeStourgeon.
1994.
The C-protein tetramer binds 230 to 240 nucleotides of pre-mRNA and nucleates the assembly of 40S heterogeneous nuclear ribonucleoprotein particles.
Mol. Cell. Biol.
14:518-533 |
| 23. | Johnson, M. H. 1981. The molecular and cellular basis of preimplantation mouse development. Biol. Rev. 56:463-498[Medline]. |
| 24. | Kawase, E., H. Suemori, N. Takahashi, K. Okazaki, K. Hashimoto, and N. Nakatsuji. 1994. Strain difference in establishment of mouse embryonic stem (ES) cell lines. Int. J. Dev. Biol. 38:385-390[Medline]. |
| 25. | Kiledjian, M., C. G. Burd, M. Gorlach, D. S. Portman, and G. Dreyfuss. 1994. Structure and function of hnRNP proteins, p. 127-149. In I. Mattaj, and K. Nagai (ed.), RNA protein interactions. Oxford University Press, Oxford, England. |
| 26. |
Laird, P. W.,
A. Zijderveld,
K. Linders,
M. A. Rudnicki,
R. Jaenisch, and A. Berns.
1991.
Simplified mammalian DNA isolation procedure.
Nucleic Acids Res.
19:4293 |
| 27. |
Ludwig, T.,
D. L. Chapman,
V. E. Papaioannou, and A. Efstratiadis.
1997.
Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos.
Genes Dev.
11:1226-1241 |
| 28. | Lupas, A. 1996. Coiled coils: new structures and new functions. Trends Biochem. Sci. 21:375-382[CrossRef][Medline]. |
| 29. |
Mayrand, S. H.,
P. Dwen, and T. Pederson.
1993.
Serine/threonine phosphorylation regulates binding of C hnRNP proteins to pre-mRNA.
Proc. Natl. Acad. Sci. USA
90:7764-7768 |
| 30. | McAfee, J., M. Huang, S. Soltaninassab, J. E. Rech, S. Iyengar, and W. M. Lestourgeon. 1997. The packaging of pre-mRNA, p. 68-102. In A. R. Krainer (ed.), Eukaryotic mRNA processing, vol. 17. IRL Press at Oxford University Press, New York, N.Y. |
| 31. | McAfee, J. G., L. Shahied-Milam, S. R. Soltaninassab, and W. M. LeStourgeon. 1996. A major determinant of hnRNP C protein binding to RNA is a novel bZIP-like RNA binding domain. RNA 2:1139-1152[Abstract]. |
| 32. | McAfee, J. G., S. R. Soltaninassab, M. E. Lindsay, and W. M. LeStourgeon. 1996. Proteins C1 and C2 of heterogeneous nuclear ribonucleoprotein complexes bind RNA in a highly cooperative fashion: support for their contiguous deposition on pre-mRNA during transcription. Biochemistry 35:1212-1222[CrossRef][Medline]. |
| 33. |
McCarthy, E., and J. Phillips.
1998.
Characterization of an intron splice enhancer that regulates alternative splicing of human GH pre-mRNA.
Hum. Mol. Genet.
7:1491-1496 |
| 34. | McLaren, A. 1976. Growth from fertilization to birth in the mouse, p. 47-51. In K. Elliott, and M. O'Connor (ed.), Embryogenesis in mammals, vol. 40. Elsevier, New York, N.Y. |
| 35. |
Merrill, B. M.,
S. F. Barnett,
W. M. LeStourgeon, and K. R. Williams.
1989.
Primary structure differences between proteins C1 and C2 of HeLa 40S nuclear ribonucleoprotein particles.
Nucleic Acids Res.
17:8441-8449 |
| 36. | Michael, W. M., M. Choi, and G. Dreyfuss. 1995. A nuclear export signal in hnRNP A1: a signal-mediated, temperature-dependent nuclear protein export pathway. Cell 83:415-422[CrossRef][Medline]. |
| 37. |
Michaud, E. J.,
S. J. Bultman,
L. J. Stubbs, and R. P. Woychik.
1993.
The embryonic lethality of homozygous lethal yellow mice (Ay/Ay) is associated with the disruption of a novel RNA-binding protein.
Genes Dev.
7:1203-1213 |
| 38. |
Mishina, Y.,
A. Suzuki,
N. Ueno, and R. R. Behringer.
1995.
Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis.
Genes Dev.
9:3027-3037 |
| 39. |
Nakielny, S., and G. Dreyfuss.
1996.
The hnRNP C proteins contain a nuclear retention sequence that can override nuclear export signals.
J. Cell Biol.
134:1365-1373 |
| 40. | Neubauer, G., A. King, J. Rappsilber, C. Calvio, M. Watson, P. Ajuh, J. Sleeman, A. Lamond, and M. Mann. 1998. Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex. Nat. Genet. 20:46-50[CrossRef][Medline]. |
| 41. |
Pinol-Roma, S.,
Y. D. Choi,
M. J. Matunis, and G. Dreyfuss.
1988.
Immunopurification of heterogeneous nuclear ribonucleoprotein particles reveals an assortment of RNA-binding proteins.
Genes Dev.
2:215-227 |
| 42. |
Pinol-Roma, S., and G. Dreyfuss.
1993.
Cell cycle-regulated phosphorylation of the pre-mRNA-binding (heterogeneous nuclear ribonucleoprotein) C proteins.
Mol. Cell. Biol.
13:5762-5770 |
| 43. | Pinol-Roma, S., and G. Dreyfuss. 1992. Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm. Nature 355:730-732[CrossRef][Medline]. |
| 44. | Portman, D. S., and G. Dreyfuss. 1994. RNA annealing activities in HeLa nuclei. EMBO J. 13:213-221[Medline]. |
| 45. | Power, M. A., and P. P. Tam. 1993. Onset of gastrulation, morphogenesis and somitogenesis in mouse embryos displaying compensatory growth. Anat. Embryol. 187:493-504[Medline]. |
| 46. | Robertson, E. J. 1987. Teratocarcinomas and embryonic stem cells: a practical approach, 1st ed. IRL Press, Washington, D.C. |
| 47. | Sambrook, J., F. Fritsch, and T. E. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 48. | Snow, M. H. L. 1976. Embryo growth during the immediate postimplantation period, p. 53-66. In K. Elliott, and M. O'Connor (ed.), Embryogenesis in mammals, vol. 40. Elsevier, New York, N.Y. |
| 49. |
Soltaninassab, S. R.,
J. G. McAfee,
L. Shahied-Milam, and W. M. LeStourgeon.
1998.
Oligonucleotide binding specificities of the hnRNP C protein tetramer.
Nucleic Acids Res.
26:3410-3417 |
| 50. | Sperling, R., and J. Sperling. 1990. Large nuclear ribonucleoprotein particles of specific RNA polymerase II transcripts, p. 453-476. In P. R. Strauss, and S. H. Wilson (ed.), The eukaryotic nucleus: molecular biochemistry and macromolecular assemblies, vol. 2. The Telford Press, Inc., Caldwell, Inc., N.J. |
| 51. |
Suzuki, A.,
J. L. de la Pompa,
R. Hakem,
A. Elia,
R. Yoshida,
R. Mo,
H. Nishina,
T. Chuang,
A. Wakeham,
A. Itie,
W. Koo,
P. Billia,
A. Ho,
M. Fukumoto,
C. C. Hui, and T. W. Mak.
1997.
Brca2 is required for embryonic cellular proliferation in the mouse.
Genes Dev.
11:1242-1252 |
| 52. |
Swanson, M. S.,
T. Y. Nakagawa,
K. LeVan, and G. Dreyfuss.
1987.
Primary structure of human nuclear ribonucleoprotein particle C proteins: conservation of sequence and domain structures in heterogeneous nuclear RNA, mRNA, and pre-rRNA-binding proteins.
Mol. Cell. Biol.
7:1731-1739 |
| 53. |
von Melchner, H.,
J. V. DeGregori,
H. Rayburn,
S. Reddy,
C. Friedel, and H. E. Ruley.
1992.
Selective disruption of genes expressed in totipotent embryonal stem cells.
Genes Dev.
6:919-927 |
| 54. |
von Melchner, H.,
S. Reddy, and H. E. Ruley.
1990.
Isolation of cellular promoters by using a retrovirus promoter trap.
Proc. Natl. Acad. Sci. USA
87:3733-3737 |
| 55. | Weighardt, F., G. Biamonti, and S. Riva. 1996. The roles of heterogeneous nuclear ribonucleoproteins (hnRNP) in RNA metabolism. Bioessays 18:747-756[CrossRef][Medline]. |
| 56. |